Ubs Group Ag Evolent Health, Inc. Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Evolent Health, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 25,000 shares of EVH stock, worth $260,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,000

Previous 25,000 -0.0%

Holding current value

$260,750

Previous $707,000 60.25%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$10.71 - $27.14 $17.6 Million - $44.5 Million	1,639,342 Added 1157.52%	1,780,967 $20 Million
Q3 2024 Nov 14, 2024	BUY	$18.41 - $32.97 $394,305 - $706,151	21,418 Added 17.82%	141,625 $4.01 Million
Q2 2024 Aug 13, 2024	SELL	$19.12 - $31.93 $473,220 - $790,267	-24,750 Reduced 17.07%	120,207 $2.3 Million
Q1 2024 May 13, 2024	BUY	$29.41 - $34.72 $570,289 - $673,255	19,391 Added 15.44%	144,957 $4.75 Million
Q4 2023 Feb 09, 2024	BUY	$23.63 - $33.52 $1.66 Million - $2.36 Million	70,422 Added 127.71%	125,566 $4.15 Million
Q3 2023 Nov 09, 2023	SELL	$25.0 - $31.4 $1.41 Million - $1.77 Million	-56,242 Reduced 50.49%	55,144 $1.5 Million
Q2 2023 Aug 11, 2023	BUY	$28.05 - $36.44 $1.42 Million - $1.84 Million	50,466 Added 82.84%	111,386 $3.37 Million
Q1 2023 May 12, 2023	SELL	$26.35 - $35.8 $283,367 - $384,993	-10,754 Reduced 15.0%	60,920 $1.98 Million
Q4 2022 Feb 08, 2023	BUY	$22.21 - $37.41 $1.3 Million - $2.2 Million	58,690 Added 452.02%	71,674 $2.01 Million
Q3 2022 Nov 10, 2022	BUY	$29.37 - $39.74 $222,977 - $301,706	7,592 Added 140.8%	12,984 $466,000
Q2 2022 Aug 10, 2022	SELL	$25.9 - $32.26 $506,422 - $630,779	-19,553 Reduced 78.38%	5,392 $166,000
Q1 2022 May 16, 2022	SELL	$22.14 - $32.3 $670,996 - $978,916	-30,307 Reduced 54.85%	24,945 $806,000
Q4 2021 Feb 14, 2022	BUY	$25.36 - $34.11 $558,198 - $750,795	22,011 Added 66.22%	55,252 $1.53 Million
Q3 2021 Nov 15, 2021	BUY	$20.93 - $31.0 $398,737 - $590,581	19,051 Added 134.26%	33,241 $1.03 Million
Q2 2021 Aug 13, 2021	SELL	$18.43 - $21.78 $659,222 - $779,048	-35,769 Reduced 71.6%	14,190 $299,000
Q1 2021 May 12, 2021	BUY	$16.19 - $21.22 $391,134 - $512,653	24,159 Added 93.64%	49,959 $1.01 Million
Q4 2020 Feb 11, 2021	SELL	$9.92 - $16.43 $49,689 - $82,297	-5,009 Reduced 16.26%	25,800 $414,000
Q3 2020 Nov 12, 2020	BUY	$7.4 - $14.33 $213,697 - $413,821	28,878 Added 1495.49%	30,809 $382,000
Q2 2020 Jul 31, 2020	SELL	$4.8 - $9.42 $1,243 - $2,439	-259 Reduced 11.83%	1,931 $14,000
Q1 2020 May 01, 2020	SELL	$3.64 - $11.77 $618 - $2,000	-170 Reduced 7.2%	2,190 $11,000
Q4 2019 Feb 14, 2020	SELL	$6.49 - $10.68 $113,523 - $186,814	-17,492 Reduced 88.11%	2,360 $21,000
Q3 2019 Nov 14, 2019	SELL	$5.82 - $8.31 $13,863 - $19,794	-2,382 Reduced 10.71%	19,852 $143,000
Q2 2019 Aug 14, 2019	BUY	$7.71 - $14.54 $45,527 - $85,858	5,905 Added 36.16%	22,234 $176,000
Q1 2019 May 14, 2019	BUY	$12.17 - $20.92 $57,551 - $98,930	4,729 Added 40.77%	16,329 $205,000
Q4 2018 Feb 14, 2019	SELL	$17.75 - $27.2 $192,392 - $294,820	-10,839 Reduced 48.3%	11,600 $231,000
Q3 2018 Nov 14, 2018	BUY	$20.1 - $28.75 $262,284 - $375,158	13,049 Added 138.97%	22,439 $637,000
Q2 2018 Aug 14, 2018	SELL	$13.8 - $23.95 $112,290 - $194,881	-8,137 Reduced 46.43%	9,390 $198,000
Q1 2018 May 15, 2018	SELL	$12.8 - $16.5 $55,360 - $71,362	-4,325 Reduced 19.79%	17,527 $250,000
Q4 2017 Feb 14, 2018	BUY	$10.5 - $18.7 $193,242 - $344,154	18,404 Added 533.76%	21,852 $268,000
Q3 2017 Nov 14, 2017	BUY	$15.65 - $24.75 $2,660 - $4,207	170 Added 5.19%	3,448 $61,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,880 Added 723.62%	3,278 $83,000
Q1 2017 Nov 14, 2017	BUY	N/A	398	398 $9,000

Others Institutions Holding EVH

# of Institutions

286

Shares Held

118M

Call Options Held

1.44M

Put Options Held

1.07M

View Full List

About Evolent Health, Inc.

Ticker EVH
Exchange NYSE
Sector Healthcare
Industry Health Information Services
Shares Outstandng 97,063,696
Market Cap $1.01B
Description
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...

More about EVH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account